Your weekly roundup of the latest news from Drug Topics®.
At this year’s Healthcare Advocate Summit, Drug Topics sat down with Kevin Hagan, President and CEO of the PAN Foundation, to discuss the importance of charitable patient assistance foundations in today’s health care landscape.
Clinical trial data from research assay has shown that Moderna’s updated COVID-19 vaccine generates a strong immune response in humans against the BA.2.86 variant.
A new study found that 1 in 8 older adults with cancer and no history of depression developed the condition for the first time during the COVID-19 pandemic.
Patients who were vaccinated and reinfected showed symptoms of few lesions, little mucosal disease, and minimal analgesia requirements.
Presented as part of the Annual Meeting of the European Association for the Study of Diabetes (EASD) meeting, the study was designed as an analysis of the ASPREE trial.